Relay Therapeutics, Inc.RLAYNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
6.83%
↓ 65% below average
Average (26q)
19.28%
Historical baseline
Range
High:449.11%
Low:-73.25%
Volatility
2708.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 6.83% |
| Q2 2025 | -13.43% |
| Q1 2025 | 8.42% |
| Q4 2024 | -11.15% |
| Q3 2024 | -16.71% |
| Q2 2024 | 11.64% |
| Q1 2024 | 6.33% |
| Q4 2023 | -4.91% |
| Q3 2023 | -7.60% |
| Q2 2023 | 6.49% |
| Q1 2023 | 23.11% |
| Q4 2022 | 0.56% |
| Q3 2022 | 10.56% |
| Q2 2022 | 17.12% |
| Q1 2022 | -0.46% |
| Q4 2021 | 15.42% |
| Q3 2021 | -73.25% |
| Q2 2021 | 449.11% |
| Q1 2021 | -2.52% |
| Q4 2020 | 28.88% |
| Q3 2020 | 12.51% |
| Q2 2020 | -0.16% |
| Q1 2020 | -3.16% |
| Q4 2019 | 22.74% |
| Q3 2019 | 11.34% |
| Q2 2019 | 22.96% |
| Q1 2019 | 0.00% |